reference/25526976

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25526976

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1459
issn	1078-0432 1557-3265
issueIdentifier	4
pageRange	1452-1459
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1452
bibliographicCitation	Lin NU, Diéras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, Roché H, Liu MC, Greil R, Ciruelos E, Loibl S, Gori S, Wardley A, Yardley D, Brufsky A, Blum JL, Rubin SD, Dharan B, Steplewski K, Zembryki D, Oliva C, Roychowdhury D, Paoletti P, Winer EP. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res. 2009 Feb 15;15(4):1452–9. doi: 10.1158/1078-0432.ccr-08-1080. PMID: 19228746.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_114e92606447e05660ec37a33ff8605c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35fd70079563a0c6b939fe6d5bc67996 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e74b51bc772035aaea40b53043e5c7e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8704cb8716f3ee43cd9421fbfb94c7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e838704c7b9dfd83f384b1cf8ce63788 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0afeb2ee8a9e7fa23dde1aa74f699b83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd1c8eddd110bfd303b6e068b94354ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7585fe25e3f93891701c00356ec0c34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea47fcf1d1298ea5004d0ecb22f49ef3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82a51e78a6e59619d2097b41be7b6f6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b44fd51fb99f50fb334dfbd2f8da48d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bd5c4914277f0a7201274725cc170bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d3a4c3667f860a8c3121061dd5572e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3704caf2bf3798f01bd3e16219e46e7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92c944d15dcab3d9e743e85a6aaf980c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8320ec4384cea481334e73f826e043d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24c92868523117a2ddef30601322008f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52b3c3ef9dccc457421aac25e1b2206c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfc1806ec90f654f8332b25dc1333f30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a99a529504610257de8ca8f7bc73804 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc08a0771987495e904062ca6deb4614 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d67c0ce3c08398c539fb3be1ce115a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_262d72705985af3d0f1cbf09cfb1fa30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a12c57bb2daf7ba1d3eef59f0f70c39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2796-1042
date	2009-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-08-1080 https://pubmed.ncbi.nlm.nih.gov/19228746
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0473129 http://id.nlm.nih.gov/mesh/M0287377 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0495206 http://id.nlm.nih.gov/mesh/M0008631
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018719Q000032 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D001932Q000188 http://id.nlm.nih.gov/mesh/D001932Q000556 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D047428Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D011799Q000009 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D000077341 http://id.nlm.nih.gov/mesh/D001932Q000401 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D000069287 http://id.nlm.nih.gov/mesh/D018719Q000037 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D005472Q000031 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005472Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8652 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 90.